Health effects of cannabis and cannabinoids and barriers to research : report to Congress pursuant to requirements of the Medical Marijuana and Cannabidiol Research Expansion Act /

Bibliographic Details
Corporate Authors:	National Institutes of Health (U.S.) (Author), United States. Congress. House. Committee on Energy and Commerce, United States. Congress. House. Committee on the Judiciary, United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, United States. Congress. Senate. Committee on the Judiciary
Format:	Government Document eBook
Language:	English
Published:	Bethesda, Maryland : Department of Health and Human Services, Public Health Service, National Institutes of Health, 2023.
Subjects:	Cannabis > Research > United States. Cannabis > Health aspects > United States. Cannabis > Therapeutic use > Effectiveness > United States. Brain > Effect of drugs on > United States. Drug, alcohol, tobacco use.
Online Access:	https://purl.fdlp.gov/GPO/gpo231692

Description
Item Description:	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP). United States federal government branch: Executive branch. Access ID (GovInfo): CMR-HE20_3000-00188604. Legal authority: Pub. L. 117-215, Sec. 401. United States Congress receiving chamber(s): United States House of Representatives and Senate. United States Congress receiving committee(s): Committee on Energy and Commerce, Committee on the Judiciary, Committee on Health, Education, Labor, and Pensions, Committee on the Judiciary. Submitted during Congress: 118th. Date issued: June 11, 2024. GPO Cataloging Record Distribution Program (CRDP).
Physical Description:	1 online resource (14 pages)
Bibliography:	Includes bibliographical references.